Other
Fluoride
0
Pipeline Programs↗
3
Active Trials↗
2
Companies Involved↗
Fluoride is an early-stage landscape with 0 programs across 2 companies. The most active players are GSK, Johnson & Johnson.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
38
clinical trials
Completed31 · 82%
Unknown status3 · 8%
Not yet recruiting2 · 5%
Enrolling by invitation1 · 3%
Withdrawn1 · 3%
Clinical Trials
Trial Activity
38 trials
A Study to Investigate Stannous Fluoride Containing Toothpaste on Antibacterial Effects in the Different Regions of the Mouth
Not yet recruiting·—·Phase 3·NCT07458464·100 enrolled
Exposed Hypersensitive Dentin Treated With Fluoride Iontophoresis With Remineralizing Agents
Enrolling by invitation·—·N/A·NCT06837779·20 enrolled
2-year Caries Clinical Study: Arginine Fluoride-Free Toothpastes vs. NaF Toothpaste
Completed·—·Phase 3·NCT05560945·6,000 enrolled
Analysis of Stannous Fluoride in GCF and Subgingival Plaque
Completed·—·N/A·NCT03296657·20 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)